Advertisement
Screener

MARINUS PHARMACEUTICALS, INC. Patents: Applications Pending

MARINUS PHARMACEUTICALS, INC. Patent Applications Pending

15 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2023-07-28: Application 63516212; Invention GANAXOLONE FOR USE IN TREATMENT OF SUPER REFRACTORY STATUS EPILEPTICUS; Applicant MARINUS PHARMACEUTICALS, INC.; Status Provisional Application Expired.
  • 2023-03-17: Application PCTUS2023064615; Invention PRODRUGS OF GANAXOLONE; Applicant MARINUS PHARMACEUTICALS, INC.; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
  • 2023-02-17: Application 63485657; Invention PRODRUGS OF GANAXOLONE; Applicant Marinus Pharmaceuticals, Inc.; Status Provisional Application Expired.
  • 2022-10-04: Application PCTUS2022077514; Invention AMORPHOUS SOLID DISPERSION GANAXOLONE FORMULATION; Applicant MARINUS PHARMACEUTICALS, INC.; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2023-07-2863516212GANAXOLONE FOR USE IN TREATMENT OF SUPER REFRACTORY STATUS EPILEPTICUSMARINUS PHARMACEUTICALS, INC.Provisional Application Expired
Henrikas Vaitkevicius
United States
2023-03-17PCTUS2023064615PRODRUGS OF GANAXOLONEMARINUS PHARMACEUTICALS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
JAY E. WROBEL
JUSTIN BARRETT SAUSKER
ALLEN B. REITZ
COLIN M. TICE
RANDALL JEFFREY BINDER
United States
United States
United States
United States
United States
2023-02-1763485657PRODRUGS OF GANAXOLONEMarinus Pharmaceuticals, Inc.Provisional Application Expired
Jay E. WROBEL
Justin Barrett SAUSKER
Allen B. REITZ
Colin M. TICE
Randall Jeffrey BINDER
United States
United States
United States
United States
United States
2022-10-04PCTUS2022077514AMORPHOUS SOLID DISPERSION GANAXOLONE FORMULATIONMARINUS PHARMACEUTICALS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
DAVID CZEKAI
VINOD TULIANI
MICHAEL SAPORITO
United States
United States
United States
2022-09-30PCTUS2022077419GANAXOLONE FOR USE IN TREATING TUBEROUS SCLEROSIS COMPLEX AND SEIZURE DISORDERSMARINUS PHARMACEUTICALS, INC.PCT - International Search Report Mailed to IB
ALEX AIMETTI
SCOTT BRAUNSTEIN
JOSEPH HULIHAN
United States
United States
United States
MATOS NEGRON, TAINA DEL MAR
2022-09-30PCTUS2022077373GANAXOLONE FOR USE IN TREATMENT OF ESTABLISHED STATUS EPILEPTICUSMARINUS PHARMACEUTICALS, INC.PCT - International Search Report Mailed to IB
HENRIKAS VAITKEVICIUS
MACIEJ GASIOR
JOSEPH HULIHAN
United States
United States
United States
MATOS NEGRON, TAINA DEL MAR
2022-08-1063396665AMORPHOUS SOLID DISPERSION GANAXOLONE FORMULATIONMarinus Pharmaceuticals, Inc.Provisional Application Expired
David CZEKAI
Vinod TULIANI
Michael SAPORITO
United States
United States
United States
2022-07-2863392878PRODRUGS OF GANAXOLONEMarinus Pharmaceuticals, Inc.Provisional Application Expired
Jay E. WROBEL
Justin Barrett Sausker
Allen B. Reitz
Colin M. Tice
Randall Jeffrey Binder
United States
United States
United States
United States
United States
2022-03-1863321302PRODRUGS OF GANAXOLONEMarinus Pharmaceuticals, Inc.Provisional Application Expired
Jay E. WROBEL
Justin Barrett Sausker
Allen B. Reitz
Colin M. Tice
Randall Jeffrey Binder
United States
United States
United States
United States
United States
2021-12-06PCTUS2021061937USE OF GANAXOLONE IN TREATING AN EPILEPSY DISORDERMARINUS PHARMACEUTICALS, INCPCT - International Search Report Mailed to IB
JOSEPH HULIHAN
ALEX AIMETTI
United States
United States
KIM, HARRY CHONG HYUN
2021-11-23PCTUS2021060459GANAXOLONE FOR USE IN TREATMENT OF SUPER REFRACTORY STATUS EPILEPTICUSMARINUS PHARMACEUTICALS, INC.PCT - International Search Report Mailed to IB
HENRIKAS VAITKEVICIUS
JOSEPH HULIHAN
MACIEJ GASIOR
United States
United States
United States
KIM, HARRY CHONG HYUN
2021-10-0463252106GANAXOLONE FOR USE IN TREATING TUBEROUS SCLEROSIS COMPLEX AND SEIZURE DISORDERSMarinus Pharmaceuticals, Inc.Provisional Application Expired
Joseph HULIHAN
Alex AIMETTI
Scott BRAUNSTEIN
United States
United States
United States
2021-10-0463252098AMORPHOUS SOLID DISPERSION GANAXOLONE FORMULATIONMarinus Pharmaceuticals, Inc.Provisional Application Expired
David CZEKAI
Vinod TULIANI
Michael SAPORITO
United States
United States
United States
2021-10-0463252090GANAXOLONE FOR USE IN TREATMENT OF ESTABLISHED STATUS EPILEPTICUSMarinus Pharmaceuticals, Inc.Provisional Application Expired
Henrikas VAITKEVICIUS
Maciej GASIOR
Joseph HULIHAN
United States
United States
United States
2020-11-2363117037GANAXOLONE FOR USE IN TREATMENT OF SUPER REFRACTORY STATUS EPILEPTICUSMarinus Pharmaceuticals, Inc.Provisional Application Expired
Henrikas VAITKEVICIUS
Maciej GASIOR
Joseph HULIHAN
United States
United States
United States